Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
PUT
KraneShares CSI China Internet ETF
KWEB
$5.22B
| $16.6M | 0.01% |
+350,500
| New | +$18.4M |
|
1477
CALL
Carvana
CVNA
$83.3B
| $16.6M | 0.01% |
275,000
+75,000
| +38% | +$4.99M |
|
1478
Teva Pharmaceuticals
TEVA
$44.4B
| $16.6M | 0.01% |
1,702,759
+1,534,493
| +912% | +$14.4M |
|
|
ARNA
1479
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $16.6M | 0.01% |
278,458
+119,611
| +75% | +$7.07M |
|
|
HI
1480
DELISTED
Hillenbrand
HI
| $16.5M | 0.01% |
387,971
+314,963
| +431% | +$13.8M |
|
1481
Cathay General Bancorp
CATY
$4.13B
| $16.5M | 0.01% |
398,891
+76,135
| +24% | +$2.97M |
|
1482
PUT
Charles River Laboratories
CRL
$14.2B
| $16.5M | 0.01% |
40,000
+5,000
| +14% | +$2.08M |
|
1483
Thor Industries
THO
$4.14B
| $16.5M | 0.01% |
134,399
+117,755
| +707% | +$13.4M |
|
1484
Cable One
CABO
$149M
| $16.5M | 0.01% |
9,092
+7,078
| +351% | +$13.9M |
|
1485
Hain Celestial
HAIN
$78.9M
| $16.5M | 0.01% |
385,205
+359,403
| +1,393% | +$14.2M |
|
|
CALY
1486
Callaway Golf Company
CALY
$2.76B
| $16.5M | 0.01% |
595,764
+33,515
| +6% | +$1.02M |
|
1487
SoFi Technologies
SOFI
$24.5B
| $16.5M | 0.01% |
1,036,476
-540,535
| -34% | -$8.47M |
|
1488
CALL
Nutrien
NTR
$34.8B
| $16.4M | 0.01% |
+200,000
| New | +$12.2M |
|
|
1489
PUT
Nutrien
NTR
$34.8B
| $16.4M | 0.01% |
+200,000
| New | +$12.2M |
|
1490
Stewart Information Services
STC
$2.12B
| $16.4M | 0.01% |
259,854
+130,661
| +101% | +$7.78M |
|
1491
CALL
CrowdStrike
CRWD
$189B
| $16.4M | 0.01% |
267,200
| – | – |
|
1492
Wolverine World Wide
WWW
$1.68B
| $16.4M | 0.01% |
549,996
+71,698
| +15% | +$2.45M |
|
1493
CALL
DexCom
DXCM
$33.6B
| $16.4M | 0.01% |
120,000
-134,000
| -53% | -$16.9M |
|
1494
DuPont de Nemours
DD
$18.4B
| $16.4M | 0.01% |
192,128
-489,591
| -72% | -$45.4M |
|
|
ECOLW
1495
CALL
DELISTED
US Ecology, Inc. Warrant
ECOLW
| $16.4M | 0.01% |
2,921,000
+15,000
| +0.5% | +$111K |
|
1496
PUT
BioNTech
BNTX
$28.6B
| $16.4M | 0.01% |
60,000
+35,000
| +140% | +$11.1M |
|
1497
ESCO Technologies
ESE
$7.17B
| $16.4M | 0.01% |
212,701
+205,984
| +3,067% | +$18.2M |
|
1498
TriNet
TNET
$3.2B
| $16.4M | 0.01% |
173,035
-65,720
| -28% | -$5.63M |
|
1499
Asbury Automotive
ABG
$3.87B
| $16.4M | 0.01% |
83,161
+63,768
| +329% | +$12M |
|
1500
PUT
Citizens Financial Group
CFG
$29.4B
| $16.4M | 0.01% |
348,200
+341,300
| +4,946% | +$15M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.